Safety of Bactrim (Sulfamethoxazole/Trimethoprim) During Lactation
Bactrim (sulfamethoxazole/trimethoprim) should be used with caution during lactation and is considered possibly safe only in healthy term babies; it should be avoided in infants who are glucose-6-phosphate dehydrogenase deficient, jaundiced, or premature. 1
Risk Assessment
- Bactrim is excreted in breast milk in small amounts (approximately 2-5% of the recommended daily dose for infants over 2 months of age) 2
- The CDC contraindicates Bactrim in nursing mothers with infants less than 2 months of age due to the risk of kernicterus (bilirubin-induced brain damage) 3
- Bactrim is specifically contraindicated in:
Potential Adverse Effects
- Sulfonamide component may cause:
- Other potential concerns include:
Alternative Antibiotics for Lactating Women
If Bactrim is contraindicated or if the infant has risk factors, consider these safer alternatives:
- Penicillins and aminopenicillins (e.g., amoxicillin) - considered compatible with breastfeeding 1, 4
- Cephalosporins - considered compatible with breastfeeding 1, 4
- Macrolides (e.g., azithromycin) - probably safe, though there is a very low risk of hypertrophic pyloric stenosis if used during the first 13 days of breastfeeding 1, 4
Clinical Decision Algorithm
Assess infant risk factors:
If no risk factors are present:
If risk factors are present:
Special Considerations
- The safety profile of Bactrim in lactation is better established than some newer antibiotics like linezolid, daptomycin, or tigecycline 5
- If Bactrim is required for maternal treatment of MRSA or other resistant infections, the benefits to the mother may outweigh the potential risks to the infant, particularly with close monitoring 5
- When treating urinary tract infections in lactating women, trimethoprim alone might be considered as an alternative with potentially fewer risks than the combination product 6